Since 1999, MaxCyte's non-viral cell engineering innovations have helped launch pioneering cell and gene therapy projects. ROCKVILLE, Md., Nov. 13, 2024 (GLOBE NEWSWIRE) -- MaxCyt ...

"Developer confidence in the market has diminished significantly, resulting in the sale of underperforming new developments," ...

Asia-Pacific markets are set for a mixed open on Thursday as investors look to the Bank of Japan's rate decision, as well as ...

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are ...

Shares of Vertex Pharmaceuticals Inc. VRTX slipped 1.26% to $470.36 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.16% ...

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq ... A replay of the conference webcast will be archived on the company’s website. Vertex is a global biotechnology company that ...

Diversified, the global technology solutions provider, has officially opened its new headquarters in Plano, Texas, marking a significant step in the company’s strategic expansion. This new facility is ...

A live webcast of management's remarks will be available through the Vertex website, www.vrtx.com in the "Investors" section under the "News and Events" page. A replay of the conference webcast will ...

Analyst Mohit Bansal from Wells Fargo maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) and keeping the price target at $555.00. Mohit Bansal has given his Buy rating ...

California Gov. Gavin Newsom and Elon Musk at Tesla’s new global engineering and AI headquarters in Palo Alto on Feb. 22, 2023. Courtesy Office of Gov. Gavin Newsom. Tesla Motors has announced ...

We expect Vertex Pharmaceuticals Incorporated VRTX to surpass expectations when it reports third-quarter 2024 results on Nov.